0001579717 false 2021 Q1 --05-31 0001579717 2021-06-01 2021-08-31 0001579717 2022-06-27 0001579717 2021-08-31 0001579717 2021-05-31 0001579717 2020-06-01 2020-08-31 0001579717 us-gaap:CommonStockMember 2021-05-31 0001579717 us-gaap:AdditionalPaidInCapitalMember 2021-05-31 0001579717 us-gaap:RetainedEarningsMember 2021-05-31 0001579717 us-gaap:CommonStockMember 2020-05-31 0001579717 us-gaap:AdditionalPaidInCapitalMember 2020-05-31 0001579717 us-gaap:RetainedEarningsMember 2020-05-31 0001579717 2020-05-31 0001579717 us-gaap:CommonStockMember 2021-06-01 2021-08-31 0001579717 us-gaap:AdditionalPaidInCapitalMember 2021-06-01 2021-08-31 0001579717 us-gaap:RetainedEarningsMember 2021-06-01 2021-08-31 0001579717 us-gaap:CommonStockMember 2020-06-01 2020-08-31 0001579717 us-gaap:AdditionalPaidInCapitalMember 2020-06-01 2020-08-31 0001579717 us-gaap:RetainedEarningsMember 2020-06-01 2020-08-31 0001579717 us-gaap:CommonStockMember 2021-08-31 0001579717 us-gaap:AdditionalPaidInCapitalMember 2021-08-31 0001579717 us-gaap:RetainedEarningsMember 2021-08-31 0001579717 us-gaap:CommonStockMember 2020-08-31 0001579717 us-gaap:AdditionalPaidInCapitalMember 2020-08-31 0001579717 us-gaap:RetainedEarningsMember 2020-08-31 0001579717 2020-08-31 0001579717 2020-06-01 2021-05-31 0001579717 2019-06-01 2020-05-31 0001579717 PRKI:NotesPayable1Member 2021-08-31 0001579717 PRKI:NotesPayable1Member 2021-05-31 0001579717 PRKI:NotesPayable2Member 2021-08-31 0001579717 PRKI:NotesPayable2Member 2021-05-31 0001579717 PRKI:NotesPayable3Member 2021-08-31 0001579717 PRKI:NotesPayable3Member 2021-05-31 0001579717 PRKI:NotesPayable4Member 2021-08-31 0001579717 PRKI:NotesPayable4Member 2021-05-31 0001579717 PRKI:NotesPayable5Member 2021-08-31 0001579717 PRKI:NotesPayable5Member 2021-05-31 0001579717 srt:ChiefExecutiveOfficerMember 2021-08-31 0001579717 srt:ChiefExecutiveOfficerMember 2021-05-31 0001579717 srt:ScenarioPreviouslyReportedMember 2020-05-31 0001579717 srt:RestatementAdjustmentMember 2020-05-31 0001579717 srt:ScenarioPreviouslyReportedMember 2020-06-01 2020-08-31 0001579717 srt:RestatementAdjustmentMember 2020-06-01 2020-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Table of Contents

 

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended August 31, 2021

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

 

Commission file number: 000-56184

 

PERK INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

46-2622704

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

     
2375 East Camelback Rd., Suite 600, Phoenix, AZ   85016
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (602) 358-7505

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Securities registered pursuant to Section 12(g) of the Act:

 

Common Stock, $.001 par value

Title of Class

 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: As of June 27, 2022, the issuer had 227,203,331 shares of its common stock issued and outstanding.

 

 

 

   

 

 

TABLE OF CONTENTS

 

PART I    
     
Item 1. Condensed Unaudited Financial Statements 3
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 11
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 14
     
Item 4. Controls and Procedures 14
     
PART II    
     
Item 1. Legal Proceedings 15
     
Item 1A. Risk Factors 15
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 15
     
Item 3. Defaults Upon Senior Securities 15
     
Item 4. Mining Safety Disclosures 15
     
Item 5. Other Information 15
     
Item 6. Exhibits 15
     
  Signatures 16

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 2 

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

 

 

INDEX TO FINANCIAL STATEMENTS

 

 

Condensed Balance Sheets as of August 31, 2021 (unaudited) and May 31, 2021 (audited) 3
   
Condensed Statements of Operations for the Three Months ended August 31, 2021 and 2020 (unaudited) 4
   
Condensed Statements of Changes in Stockholders’ Deficit for the Three Months ended August 31, 2021 and 2020 (unaudited) 5
   
Condensed Statements of Cash Flows for the Three Months ended August 31, 2021 and 2020 (unaudited) 6
   
Notes to Condensed Financial Statements (unaudited) 7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 3 

 

 

 

PERK INTERNATIONAL INC.

CONDENSED BALANCE SHEETS

 

           
    August 31, 2021    May 31, 2021 
ASSETS   (Unaudited)    (Audited) 
Current Assets:          
Cash  $7,560   $28,934 
Total Assets  $7,560   $28,934 
           
LIABILITIES AND STOCKHOLDERS' DEFICIT          
           
Current Liabilities:          
Accounts payable  $22,000   $29,755 
Accrued interest   25,160    22,022 
Due to related parties   9,163    9,163 
Notes payable   91,749    91,749 
Total Current Liabilities   148,072    152,689 
Total Liabilities   148,072    152,689 
           
Commitments and contingencies        
           
Stockholders' Deficit:          
Common Stock, par value $0.001, 950,000,000 shares authorized; 227,203,331 and 227,203,331 shares issued and outstanding, respectively   22,720    22,720 
Additional paid-in capital   1,028,408    1,028,408 
Accumulated deficit   (1,191,640)   (1,174,883)
Total Stockholders' Deficit   (140,512)   (123,755)
Total Liabilities and Stockholders' Deficit  $7,560   $28,934 

 

The accompanying notes are an integral part of these condensed unaudited financial statements.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 4 

 

 

 

PERK INTERNATIONAL INC.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

 

           
   For the Three Months Ended
August 31,
 
   2021   2020 
Operating Expenses:          
General and administrative  $13,619   $22,474 
Total operating expenses   13,619    22,474 
           
Loss from operations  $(13,619)  $(22,474)
           
Other expense:          
Interest expense   (3,138)   (2,065)
Total other expense   (3,138)   (2,065)
           
Net loss before provision for income tax   (16,757)   (24,539)
Provision for income tax        
Net Loss  $(16,757)  $(24,539)
           
Loss per share, basic and diluted  $(0.00)  $(0.00)
           
Weighted average common shares outstanding, basic and diluted   227,203,331    227,203,331 

 

The accompanying notes are an integral part of these condensed unaudited financial statements.

 

 

 

 

 

 

 

 5 

 

 

PERK INTERNATIONAL INC.

CONDENSED STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR THE THREE MONTHS ENDED AUGUST 31, 2022 AND 2021

(Unaudited)

 

                          
    Common Stock    

Additional

Paid-in

    

Accumulated

    

Total

Stockholders'

 
    Shares    Amount    Capital    Deficit    Deficit 
Balance, May 31, 2021   227,203,331   $22,720   $1,028,408   $(1,174,883)  $(123,755)
Net loss               (16,757)   (16,757)
Balance, August 31, 2021   227,203,331   $22,720   $1,028,408   $(1,191,640)  $(140,512)

 

    Common Stock    

Additional

Paid-in

    

Accumulated

    

Total

Stockholders'

 
    Shares    Amount    Capital    Deficit    Deficit 
Balance, May 31, 2020   227,203,331   $22,720   $1,028,408   $(1,542,924)  $(491,796)
Net loss               (24,539)   (24,539)
Balance, August 31, 2020   227,203,331   $22,720   $1,028,408   $(1,567,463)  $(516,335)

 

The accompanying notes are an integral part of these condensed unaudited financial statements.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 6 

 

 

PERK INTERNATIONAL INC.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

 

           
   For the Three Months Ended August 31, 
   2021   2020 
Cash flows from operating activities:          
Net Loss  $(16,757)  $(24,539)
Adjustments to reconcile net loss to net cash used in operating activities:          
Changes in operating assets and liabilities:          
Accounts payable   (7,755)   17,830 
Accrued interest   3,138    2,065 
Net cash used in operating activities   (21,374)   (4,644)
           
Cash flows from investing activities:        
           
Cash flows from financing activities:          
Cash advances from a related party       4,644 
Net cash provided by financing activities       4,644 
           
Net change in cash   (21,374)    
           
Cash, beginning of period   28,934     
           
Cash, end of period  $7,560   $ 
           
Supplemental disclosure of cash flow information:          
Cash paid for taxes  $   $ 
Cash paid for interest  $   $ 

 

The accompanying notes are an integral part of these condensed unaudited financial statements.

 

 

 

 

 

 

 

 

 7 

 

 

PERK INTERNATIONAL INC.

NOTES TO CONDENSED UNAUDITED FINANCIAL STATEMENTS

AUGUST 31, 2021

 

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Perk International Inc. (“the Company” or “Perk”) was incorporated under the laws of the State of Nevada on April 10, 2013. The Company is an acquisition, sales management company for early stage, high growth businesses and technologies in the health care industry. The Company has developed specific criteria and standards that must be met by each acquisition candidate. Once identified, the Company will engage its highly seasoned and well-trained team of industry professionals to perform thorough due diligence on the potential acquisition partner. Following successful due diligence, Perk will send in its M & A team to structure and present an attractive proposal to the selling entity.

 

On February 22, 2019, Marcus Southworth became, President, Secretary, Treasurer and Director of Perk International Inc.

 

On April 27, 2020, Certification and Notice of Termination of Registration Under Section 12(g) of The Securities Exchange Act of 1934 of Duty to File Reports Under Sections 13 and 15 (d) of the Securities Exchange Act of 1934.

 

On April 30, 2020, Marcus resigned from, President, Secretary, Treasurer and Director of Perk International Inc. Mr. Southworth no longer holds any officer position with Perk International Inc.

 

On April 30, 2020, Nelson Grist became the sole director of Perk International Inc.

 

On April 13, 2021, the Company filed its Form 10 (Amendment No. 7).

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

The Company’s unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying unaudited condensed financial statements reflect all adjustments, consisting of only normal recurring items, which, in the opinion of management, are necessary for a fair statement of the results of operations for the periods shown and are not necessarily indicative of the results to be expected for the full year ending May 31, 2022. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended May 31, 2021.

 

Use of estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.

 

Concentrations of Credit Risk

We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”).

 

Cash equivalents

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents for the years ended May 31, 2021 or 2020.

 

 

 

 

 8 

 

 

Fair value of financial instruments

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

 

Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

 

Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

 

Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data.

  

The carrying amount of the Company’s financial assets and liabilities, such as cash, prepaid expenses and accrued expenses approximate their fair value because of the short maturity of those instruments. The Company’s notes payable approximates the fair value of such instruments based upon management’s best estimate of interest rates that would be available to the Company for similar financial arrangements at May 31, 2021 and 2020.

 

Basic and Diluted Earnings Per Share

Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The weighted average number of common shares outstanding and potentially outstanding common shares assumes that the Company incorporated as of the beginning of the first period presented. There were no dilutive shares as of May 31, 2021 and 2020.

 

Stock-based compensation

We account for equity-based transactions with employees and non-employees under the provisions of FASB ASC Topic 718, “Compensation – Stock Compensation” (Topic 718), which establishes that equity-based payments to employees and non-employees are recorded at the grant date the fair value of the equity instruments the entity is obligated to issue when the employees and non-employees have rendered the requisite service and satisfied any other conditions necessary to earn the right to benefit from the instruments. Topic 718 also states that observable market prices of identical or similar equity or liability instruments in active markets are the best evidence of fair value and, if available, should be used as the basis for the measurement for equity and liability instruments awarded in these share-based payment transactions. However, if observable market prices of identical or similar equity or liability instruments are not available, the fair value shall be estimated by using a valuation technique or model that complies with the measurement objective, as described in FASB ASC Topic 718.

 

Recently Adopted Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

NOTE 3 - GOING CONCERN

 

The Company’s financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not established any source of revenue to cover its operating costs. The Company has an accumulated deficit of $1,191,640 and a working capital deficit of $140,512 as of August 31, 2021. The Company had an accumulated deficit of $1,174,883 and a working capital deficit of $123,755 as of May 31, 2021. The Company will engage in limited activities without incurring significant liabilities that must be satisfied in cash until a source of funding is secured. The Company will offer noncash consideration and seek equity lines as a means of financing its operations. If the Company is unable to obtain revenue producing contracts or financing or if the revenue or financing it does obtain is insufficient to cover any operating losses it may incur, it may substantially curtail or terminate its operations or seek other business opportunities through strategic alliances, acquisitions or other arrangements that may dilute the interests of existing stockholders.

 

 

 

 9 

 

 

NOTE 4 - NOTES PAYABLE

 

On November 3, 2016, the Company received a $25,000 loan from Securities Compliance Group, Ltd. The note is unsecured, bears interest at 25% and was due upon the final order of dismissal of the custodianship. On October 20, 2022, the note was assigned to Kim Southworth. As of August 31, 2021 and May 31, 2021, there is $19,777 and $18,202 of interest accrued on this loan, respectively. This note is in default.

  

On May 2, 2019, the Company executed a promissory note with Kim Southworth in the amount of $14,749. The loan is due either on demand or within five years and carries an interest rate of 6%, compounded annually. As of August 31, 2021 and May 31, 2021, there is $2,156 and $1,905 of interest accrued on this loan, respectively.

 

On December 16, 2020, the Company received a $12,000 loan from GPL Ventures, LLC. The note is unsecured, bears interest at 10% and matures on December 16, 2021. As of August 31, 2021 and May 31, 2021, there is $848 and $546 of interest accrued on this loan, respectively.

 

On March 17, 2021, the Company received a $10,000 loan from GPL Ventures, LLC. The note is unsecured, bears interest at 10% and matures on March 17, 2022. As of August 31, 2021 and May 31, 2021, there is $1,458 and $1,205 of interest accrued on this loan ($1,000 of which is related to processing fees), respectively.

 

On May 11, 2021, the Company received a $30,000 loan from GPL Ventures, LLC. The note is unsecured, bears interest at 10% and matures on May 11, 2022. As of August 31, 2021 and May 31, 2021, there is $921 and $164 of interest accrued on this loan, respectively.

 

NOTE 5 – RELATED PARTY TRANSACTIONS

 

As of August 31, 2021 and May 31, 2021, the Company owed the CEO $9,163 and $9,163 for cash advances to the Company. The advances were used to pay for certain operating expenses. They are unsecured, non-interest bearing and due on demand.

 

NOTE 6 – COMMON STOCK

 

On March 17, 2021, the Company amended its Articles of Incorporation increasing its authorized common stock from 250,000,000 to 950,000,000 shares.

 

NOTE 7 – CORRECTION OF AN ERROR

 

During 2021, the Company discovered that interest expense was wrongly recorded in the financial statements for the fiscal year ended May 31, 2020. Consequently, interest expenses and the related liability were understated. These errors have now been corrected by restating each of the affected financial statement line items for prior periods. The previous year audited numbers and restated numbers are as follows:

                
As of May 31, 2020
   As Reported   Adjusted   As Restated 
Accounts payable  $343,319   $   $343,319 
Accrued interest   962    12,158    13,120 
Due to related parties   24,340        24,340 
Loans payable   71,268        71,268 
Notes payable   39,749        39,749 
Total current liabilities   479,638    12,158    491,796 
                
Common stock   22,720        22,720 
Additional paid-in capital   1,028,408        1,028,408 
Accumulated deficit   (1,530,766)       (1,542,924)
Total stockholders' deficit   (479,638)   (12,158)   (491,796)
Total liabilities and stockholders' equity  $   $   $ 

 

 

 

 

 

 10 

 

 

                
For the Three Months Ended August 31, 2020
   As Reported   Adjustment     As Restated  
Operating Expenses:                  
General and administration expenses  $22,474   $   $ 22,474  
Total operating expense   22,474         22,474  
Loss from operations   (22,474)        (22,474 )
                   
Other expense:                  
Interest expense   (13,765)   (11,700)    (2,065 )
Total other expense   (13,765)   (11,700)    (2,065 )
                   
Net Loss  $(36,239)  $(11,700)  $ $(24,539 )
                   
Net loss per share  $(0.00)       $ (0.00 )
                   
Weighted average shares outstanding—basic and diluted   227,203,331          227,203,331  

 

NOTE 8 - SUBSEQUENT EVENTS

 

In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were issued and has determined that it does not have any material subsequent events to disclose in these financial statements other than the following.

 

On January 17, 2022, the Company issued a Convertible Promissory Note to a third party in the amount of $100,000. The note bears interest at 10% per annum and matures on June 17, 2022. The Note is convertible into shares of the Company’s common stock at $0.0001 per share.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 11 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following information should be read in conjunction with our financial statements and related notes thereto included in Part I, Item 1, above.

 

Forward Looking Statements

 

Certain matters discussed herein are forward-looking statements. Such forward-looking statements contained in this Form 10-Q involve risks and uncertainties, including statements as to:

·   our future strategic plans;
·   our future operating results;
·   our business prospects;
·   our contractual arrangements and relationships with third parties;
·   the dependence of our future success on the general economy;
·   our possibility of not successfully raising future financings; and
·   the adequacy of our cash resources and working capital.

 

These forward-looking statements can generally be identified as such because the context of the statement will include words such as we “believe,” “anticipate,” “expect,” “estimate” or words of similar meaning. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which are described in close proximity to such statements and which could cause actual results to differ materially from those anticipated. Shareholders, potential investors and other readers are urged to consider these factors in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included herein are only made as of the date of this Form 10-Q, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

 

Business Overview

 

General

 

Perk International, Inc. is an acquisition, sales management company for early stage, high growth businesses and technologies in the health care industry. The Company has developed specific criteria and standards that must be met by each acquisition candidate. Once identified, the Company will have access to highly seasoned and well-trained team of industry professionals to perform thorough due diligence on the potential acquisition partner. Following successful due diligence, Perk International, Inc. We will be able to consult with M & A advisors to structure and present an attractive proposal to the selling entity.

 

Perk International, Inc., now feels very comfortable in entering the rapidly growing health care market. It is estimated that Holistic and other natural and organic ingredients are believed to provide many medical benefits. It has been reported that Holistic and Natural Ingredients may be able to treat hundreds of medical issues.

 

 

 

 12 

 

 

Our Objective

 

It is the objective of Perk International, Inc. to control every aspect of the natural and organic farming industry from growth to extraction and distribution. This will enable us to avoid risking stagnant or contaminated biomass because of third party extraction labs being at full capacity.

 

Perk International, Inc., has designed its future into a 3-stage rollout:

 

  1. Grow and distribute high grade, certified natural and organic ingredients.
     
  2. Own or invest in facilities to manufacturer skincare and supplements
     
  3. Provide international wholesale distribution of natural and organic health care products and acquire and open Med Spa’s through the United States and the World.

 

To reach this objective we have hand-picked a team of industry professionals from experience

 

Our ultimate objective is to achieve exceptional multiples in growth, valuation and revenue to Perk International, “Inc. and its shareholders.

 

Results of Operation for the Three Months Ended August 31, 2021 compared to the Three Months Ended August 31, 2020

 

General and administrative

For the three months ended August 31, 2021 we incurred $13,619 of general and administrative expense (“G&A”) compared to $22,474 for the three months ended August 31, 2020, a decrease of $8,855 or 39.4%.

 

Other expense

For the three months ended August 31, 2021, we had interest expense of $3,138 compared to $2,065 for the three months ended August 31, 2020. The increase in interest expense is due to the accrual of interest on our loans and notes payable.

 

Net loss

For the three months ended August 31, 2021 the Company had a net loss of $16,757 as compared to $24,539 in the prior period.

 

Liquidity and Capital Resources

 

For the three months ended August 31, 2021 we used $21,378 in operations compared to $4,644 in the prior period.

 

For the three months ended August 31, 2021, we neither used nor received cash from financing activities, compared to $4,644 received from a related party in the prior period.

 

Critical Accounting Estimates and Policies

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Note 2 to the Financial Statements describes the significant accounting policies and methods used in the preparation of the Financial Statements. Estimates are used for, but not limited to, contingencies and taxes.  Actual results could differ materially from those estimates. The following critical accounting policies are impacted significantly by judgments, assumptions, and estimates used in the preparation of the Financial Statements.

 

 

 

 13 

 

 

We are subject to various loss contingencies arising in the ordinary course of business. We consider the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss contingencies.  An estimated loss contingency is accrued when management concludes that it is probable that an asset has been impaired or a liability has been incurred and the amount of the loss can be reasonably estimated.  We regularly evaluate current information available to us to determine whether such accruals should be adjusted.

 

We recognize deferred tax assets (future tax benefits) and liabilities for the expected future tax consequences of temporary differences between the book carrying amounts and the tax basis of assets and liabilities.  The deferred tax assets and liabilities represent the expected future tax return consequences of those differences, which are expected to be either deductible or taxable when the assets and liabilities are recovered or settled.  Future tax benefits have been fully offset by a 100% valuation allowance as management is unable to determine that it is more likely than not that this deferred tax asset will be realized.

 

Recent Accounting Pronouncements

 

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable to smaller reporting companies.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to be effective in providing reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the “SEC”), and that such information is accumulated and communicated to our management to allow timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, they concluded that our disclosure controls and procedures were not effective for the quarterly period ended August 31, 2021.

 

The following aspects of the Company were noted as potential material weaknesses:

·   lack of an audit committee
·   lack of segregation of duties

 

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs.

 

Changes in Internal Controls

 

Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that no change occurred in the Company's internal controls over financial reporting during the quarter ended August 31, 2021, that has materially affected, or is reasonably likely to materially affect, the Company's internal controls over financial reporting.

 

 

 

 

 

 

 14 

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item; however, due to the current circumstance we have chosen to include the following risk factor.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINING SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

None

 

ITEM 6. EXHIBITS

 

Exhibit Number   Description
31.1   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (*)
31.2   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (*)
32.1   Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (*)
101.INS*   Inline XBRL Instance Document.
101.SCH*   Inline XBRL Taxonomy Extension Schema Document.
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*filed herewith

 

 

 

 15 

 

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: July 1, 2022 By: /s/ Nelson Grist
  Name: Nelson Grist
  Title: Chief Executive Officer
(Principal Executive Officer)
    Chief Financial Officer
(Principal Financial and Accounting Officer)

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 16 

Perk (CE) (USOTC:PRKI)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Perk (CE) Charts.
Perk (CE) (USOTC:PRKI)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Perk (CE) Charts.